Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.680
-0.110 (-6.15%)
At close: Nov 13, 2026, 4:00 PM EST
1.850
+0.170 (10.12%)
After-hours: Nov 13, 2026, 6:48 PM EST
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $2.74 million as of November 13, 2026. It is the 46,965th most valuable company in the world and the 6,212th biggest in the United States. Its market cap has decreased by 78.30% in one year.
Market Cap
2.74M
Enterprise Value
-2.52M
1-Year Change
-78.30%
Global Rank
Country Rank
#6,212 United States
Category
ChartMarket Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.27M to $2.74M, a decrease of -98.61%. That is a compound annual growth rate of -53.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.74M | -70.88% |
| Dec 31, 2025 | 9.42M | -37.64% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.18% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 3.95M |
| Traws Pharma | 3.84M |
| Azitra | 3.55M |
| Silo Pharma | 3.45M |
| KALA BIO | 3.31M |
| NeuroSense Therapeutics | 3.29M |
| Mustang Bio | 3.24M |
| Dermata Therapeutics | 2.88M |